CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-25 | Riggsbee Richard Bryan Chief Financial Officer | Returned to the company | −6,653 | $46.65 | $310K | 162,235 |
| 2018-09-25 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,952 | $46.65 | $138K | 129,578 |
| 2018-09-25 | Verratti Mark President Assurex Health Inc. | Returned to the company | −2,897 | $46.65 | $135K | 86,303 |
| 2018-09-25 | King Gary A. Exec. VP International Ops | Returned to the company | −3,327 | $46.65 | $155K | 141,126 |
| 2018-09-25 | Capone Mark Christopher President & C.E.O. | Returned to the company | −18,295 | $46.65 | $853K | 467,855 |
| 2018-09-25 | Sanders Walter Lloyd President Myriad Oncology | Returned to the company | −1,664 | $46.65 | $78K | 37,453 |
| 2018-09-25 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,544 | $46.65 | $259K | 176,750 |
| 2018-09-25 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −5,544 | $46.65 | $259K | 154,716 |
| 2018-09-19 | Ford Alexander President, MGL | Grant or award | +60,000 | 135,660 | ||
| 2018-09-19 | Tobin Bernard President Crescendo BioScience | Grant or award | +35,000 | 177,551 | ||
| 2018-09-19 | Riggsbee Richard Bryan Chief Financial Officer | Grant or award | +60,000 | 168,888 | ||
| 2018-09-19 | McDade Ralph L President Myriad RBM, Inc. | Grant or award | +27,000 | 132,530 | ||
| 2018-09-19 | Verratti Mark President Assurex Health Inc. | Grant or award | +40,000 | 89,200 | ||
| 2018-09-19 | King Gary A. Exec. VP International Ops | Grant or award | +27,000 | 144,453 | ||
| 2018-09-19 | Capone Mark Christopher President & C.E.O. | Grant or award | +165,000 | 486,150 | ||
| 2018-09-19 | LANCHBURY JERRY S Chief Scientific Officer | Grant or award | +50,000 | 182,294 | ||
| 2018-09-19 | MARSH RICHARD M E.V.P., General Counsel | Grant or award | +50,000 | 160,260 | ||
| 2018-09-17 | Ford Alexander President, MGL | Returned to the company | −1,830 | $46.35 | $85K | 75,660 |
| 2018-09-17 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −3,148 | $46.35 | $146K | 105,530 |
| 2018-09-17 | King Gary A. Exec. VP International Ops | Returned to the company | −5,101 | $46.35 | $236K | 117,453 |
Page 39 of 60 · 1,194 trades